You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 信立泰(002294.SZ)漲4% 授權管理層啟動分拆子公司境內上市前期籌備工作
格隆匯 12-14 09:59
格隆匯12月14日丨信立泰(002294.SZ)現報26元,漲4%,暫成交7456萬元,最新總市值271億元。信立泰上週五(11日)晚間公佈,為進一步拓寬公司融資渠道,將授權公司經營管理層啟動分拆全資子公司深圳市信立泰生物醫療工程有限公司境內上市前期籌備工作。同日,公司還公佈:擬以自有資金及子公司股權增資生物醫療;擬將“重組人促卵泡激素-CTP融合蛋白注射液”中國大陸地區的全部技術所有權和知識產權轉讓給金賽藥業;擬由子公司生物醫療收購雅倫生物股權;籌劃第二期員工持股計劃等。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account